Detailed Information on Publication Record
2024
Multifunctional graphene quantum dots: A therapeutic strategy for neurodegenerative diseases by regulating calcium influx, crossing the blood-brain barrier and inhibiting Aβ-protein aggregation
GOMEZ PEREZ, Inmaculada Jennifer, Petra KŘÍŽKOVÁ, Anna DOLEČKOVÁ, Lucía CARDO, Cecilia WETZL et. al.Basic information
Original name
Multifunctional graphene quantum dots: A therapeutic strategy for neurodegenerative diseases by regulating calcium influx, crossing the blood-brain barrier and inhibiting Aβ-protein aggregation
Authors
GOMEZ PEREZ, Inmaculada Jennifer (724 Spain, belonging to the institution), Petra KŘÍŽKOVÁ (203 Czech Republic, belonging to the institution), Anna DOLEČKOVÁ (203 Czech Republic, belonging to the institution), Lucía CARDO, Cecilia WETZL, Naděžda PIZÚROVÁ, Maurizio PRATO, Jiřina MEDALOVÁ (203 Czech Republic, guarantor, belonging to the institution) and Lenka ZAJÍČKOVÁ (203 Czech Republic, belonging to the institution)
Edition
Applied Materials Today, Elsevier Ltd, 2024, 2352-9407
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10610 Biophysics
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 8.300 in 2022
Organization unit
Faculty of Science
UT WoS
001171819100001
Keywords in English
Bioimaging; Blood-brain barrier; Carbon dots; Memantine; Protein aggregation
Tags
Tags
International impact, Reviewed
Změněno: 28/3/2024 09:42, Mgr. Marie Šípková, DiS.
Abstract
V originále
Multifunctional nanoparticles could be the hallmark for the treatment of neurodegenerative diseases. Dissociation of protein aggregates causing neuronal damage and transfer of specific drugs which can downregulate neuronal excitotoxicity by inhibiting glutamatergic N-Methyl-d-Aspartate-receptors (NMDA) and then reducing calcium influx are among the main factors to consider for proper therapy. Here, we present a multiplatform based on nitrogen-doped graphene quantum dots (NGQDs) with such functionalities. The NGQDs were functionalized with Memantine, the clinically used drug, via covalent and non-covalent coupling, and we confirmed that the pharmaceutical activity was not altered. Apart from that, using xCELLigence technology and flow cytometric analysis of ABC transporter function, we uncovered that the ABC transporters of the blood-brain barrier (BBB) do not affect the ability of NGQD to cross BBB. Surprisingly, this study found that NGQDs have an inhibitory effect on NMDA receptors, thus supporting the action of Memantine. Moreover, NGQDs and their derivatives demonstrated the potential to dissociate β-amyloid aggregates while possessing features suitable for bioimaging in various cell lines.
Links
EF20_079/0017045, research and development project |
| ||
LM2018121, research and development project |
| ||
90110, large research infrastructures |
|